Literature DB >> 8624318

Vulvar intraepithelial neoplasia: long term follow up of treated and untreated women.

J J Herod1, M I Shafi, T P Rollason, J A Jordan, D M Luesley.   

Abstract

OBJECTIVE: To investigate the long term outcome of patients with vulvar intraepithelial neoplasia.
DESIGN: A retrospective study using information obtained from patient casenotes. SAMPLE: One hundred and thirty-three women with a primary diagnosis of vulvar intraepithelial neoplasia (VIN), identified during a 15-year period.
RESULTS: The diagnosis of vulvar intraepithelial neoplasia increased throughout the study period. Human papilloma virus changes were noted in 104 patients (78%); these women were significantly younger than those without (P < or = 0.001). Nineteen (14%) were managed by observation or medical treatment and the remainder by surgical methods. Histological or symptomatic recurrence after surgical treatment occurred in 55 (48%). When disease recurred, it usually did so within four years of treatment. Recurrence was more common following laser vapourisation than after local excision (75% vs 40%; P < or = 0.01). Progression to invasive disease occurred in nine patients (7%), none of whom were in the group being observed. Four deaths occurred in this group, three from gynaecological malignancies of the lower genital tract.
CONCLUSION: Patients with vulvar intraepithelial neoplasia require long term follow up, and the risk of invasion may be higher than previously thought. Surgical treatment when required should be by excisional rather than ablative methods in most instances. In selected cases it is also possible to safely manage patients by more conservative methods.

Entities:  

Mesh:

Year:  1996        PMID: 8624318     DOI: 10.1111/j.1471-0528.1996.tb09771.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  9 in total

Review 1.  Human papillomavirus infection with particular reference to genital disease.

Authors:  C Sonnex
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

2.  Vulval Intraepithelial Neoplasia 3: A Clinico-Pathological Review in a Tertiary Care Centre Over 10 Years.

Authors:  Karthik C Bassetty; Anitha Thomas; Rachel G Chandy; Dhanya S Thomas; Vinotha Thomas; Abraham Peedicayil; Ajit Sebastian
Journal:  J Obstet Gynaecol India       Date:  2022-04-06

3.  Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence.

Authors:  J J Wallbillich; H E Rhodes; A M Milbourne; M F Munsell; M Frumovitz; J Brown; C L Trimble; K M Schmeler
Journal:  Gynecol Oncol       Date:  2012-08-04       Impact factor: 5.482

Review 4.  Therapy of human papillomavirus-related disease.

Authors:  Peter L Stern; Sjoerd H van der Burg; Ian N Hampson; Thomas R Broker; Alison Fiander; Charles J Lacey; Henry C Kitchener; Mark H Einstein
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

5.  The re-infection rate of high-risk HPV and the recurrence rate of vulvar intraepithelial neoplasia (VIN) usual type after surgical treatment.

Authors:  Antonio Frega; Francesco Sopracordevole; Paolo Scirpa; Alberto Biamonti; Laura Lorenzon; Simona Scarani; Luana De Sanctis; Arianna Pacchiarotti; Massimo Moscarini; Deborah French
Journal:  Med Sci Monit       Date:  2011-09

6.  Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Trial Protocol.

Authors:  Helen C Stankiewicz Karita; Kirsten Hauge; Amalia Magaret; Constance Mao; Jeffrey Schouten; Verena Grieco; Long Fu Xi; Denise A Galloway; Margaret M Madeleine; Anna Wald
Journal:  JAMA Netw Open       Date:  2019-04-05

7.  Photodynamic therapy for gynecological diseases and breast cancer.

Authors:  Natashis Shishkova; Olga Kuznetsova; Temirbolat Berezov
Journal:  Cancer Biol Med       Date:  2012-03       Impact factor: 4.248

8.  Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia.

Authors:  Mathias K Fehr; Marc Baumann; Michael Mueller; Daniel Fink; Siegfried Heinzl; Patrick Imesch; Konstantin Dedes
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

9.  Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3).

Authors:  Margaret M Madeleine; Lisa G Johnson; David R Doody; Elaine R Tipton; Joseph J Carter; Denise A Galloway
Journal:  J Low Genit Tract Dis       Date:  2016-07       Impact factor: 1.925

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.